 |
市場調查報告書
商品編碼
1485249
仿生眼市場 - 按眼睛類型、技術、適應症、最終用途 - 全球預測，2024 年 - 2032 年Bionic Eye Market - By Eye Type, Technology, Indication, End-use - Global Forecast, 2024 - 2032 |
||||||
由於技術進步和客製化選項的可用性，2024 年至 2032 年間，全球仿生眼市場規模將以 11.6% 的複合年成長率成長。
隨著微電子和機器人技術的不斷創新，仿生眼提供了改進的視覺能力。此外，患者現在可以為其植入物提供多種客製化選項，包括顏色選擇和設計。這種個人化提高了患者滿意度並鼓勵採用。隨著意識的增強和越來越多的人尋求增強的視覺解決方案，先進技術和客製化的結合將推動仿生眼產業的顯著擴張。例如，2023 年 8 月，HumanOptics 推出了一種新型優質虹膜植入物，透過為患者量身定做的創新選項擴大了其顏色選擇範圍。
仿生眼市場根據眼睛類型、技術、適應症、最終用途和地區進行細分。
由於機械仿生眼的強勁性能和長期可靠性，到 2032 年，機械細分市場將呈現健康的成長速度。憑藉其耐用且經過驗證的設計，機械仿生眼為視力恢復提供了穩定的選擇。隨著生物力學的進步不斷提高機械植入物的功能和壽命，它們仍然是患者和臨床醫生的熱門選擇。機械領域專注於提供可靠且有效的視覺解決方案，將佔據重要的仿生眼市場。
由於眼科診所在提供和促進這些先進視覺修復術的採用方面發揮關鍵作用，眼科診所部分將在 2024 年至 2032 年期間獲得顯著成長。這些診所是仿生眼植入手術、病人諮詢和術後護理的重要中心。眼科診所專注於眼睛健康和視力恢復，並處於仿生眼創新的前沿。他們的專業知識、專業設施和全面的患者支援佔據了該細分市場的最大佔有率，滿足了對視力增強技術日益成長的需求。
亞太地區仿生眼產業將在 2024 年至 2032 年間呈現顯著的複合年成長率，原因是其龐大的人口、不斷增加的醫療支出以及視力障礙盛行率的上升。中國和日本等國在仿生眼研發上表現突出。此外，該地區人口老化加劇了對視力恢復技術的需求。由於高度重視醫療保健的進步和可及性，亞太地區將成為仿生眼產業的主要貢獻者，反映出其在塑造視覺義肢未來方面的關鍵作用。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 視力喪失和其他慢性眼疾的盛行率不斷上升
- 增加私人和公共組織的資助
- 科技發展日新月異
- 產業陷阱與挑戰
- 目標族群認知度低
- 與這些程序相關的高成本
- 成長動力
- 成長潛力分析
- 監管環境
- 技術景觀
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司市佔率分析
- 競爭定位矩陣
- 戰略展望矩陣
第 5 章：市場估計與預測：按眼睛類型，2018 - 2032
- 主要趨勢
- 外眼
- 植入眼
第 6 章：市場估計與預測：按技術分類，2018 年 - 2032 年
- 主要趨勢
- 電子的
- 機械的
- 其他技術
第 7 章：市場估計與預測：按指標分類，2018 年 - 2032 年
- 主要趨勢
- 視力喪失和障礙
- 色素性視網膜炎
- 乾性老年黃斑部病變
- 其他適應症
第 8 章：市場估計與預測：按最終用途分類，2018 年 - 2032 年（百萬美元）
- 主要趨勢
- 醫院
- 眼科診所
- 其他最終用戶
第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
- 亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區
第 10 章：公司簡介
- Bionic Eye Technologies, Inc.
- Bionic Vision Technologies
- iBionics
- Monash Vision Group
- Nidek Co. Ltd.
- Optobionics
- Pixium Vision SA
- Schott
- Second Sight Medical Products, Inc.
- Vivani Medical, Inc.
Global Bionic Eye Market Size will grow at 11.6% CAGR between 2024 and 2032, owing to technological advancements and the availability of customization options.
With ongoing innovations in microelectronics and robotics, bionic eyes offer improved vision capabilities. Moreover, patients now have a wide range of customization options for their implants, including color selection and design. This personalization enhances patient satisfaction and encourages adoption. As awareness grows and more individuals seek enhanced vision solutions, the combination of advanced technology and customization will drive significant expansion in the bionic eye industry. For instance, in August 2023, HumanOptics introduced a novel premium iris implant, expanding its color selection range with innovative options for patients' customization.
The bionic eye market is segmented based on eye type, technology, indication, end-use, and region.
The mechanical segment will exhibit a healthy growth rate through 2032 due to the mechanical bionic eye's robust performance and long-standing reliability. With their durable and proven designs, mechanical bionic eyes offer a stable option for vision restoration. As advancements in biomechanics continue to enhance the functionality and longevity of mechanical implants, they remain a popular choice among patients and clinicians. With a focus on providing dependable and effective vision solutions, the mechanical segment will capture a significant bionic eye market share.
The ophthalmic clinic segment will garner notable gains over 2024-2032, driven by the pivotal role of ophthalmic clinics in providing access to and facilitating the adoption of these advanced visual prosthetics. These clinics serve as essential hubs for bionic eye implantation surgeries, patient consultations, and post-operative care. With a focus on eye health and vision restoration, ophthalmic clinics are at the forefront of bionic eye innovation. Their expertise, specialized facilities, and comprehensive patient support contribute to the segment's largest share, meeting the increasing demand for vision-enhancing technologies.
Asia Pacific bionic eye industry will demonstrate a noteworthy CAGR between 2024 and 2032, driven by its vast population, increasing healthcare expenditure, and rising prevalence of visual impairments. Countries like China and Japan are prominent in bionic eye research and development. Moreover, the region's aging population fuels the demand for vision-restoring technologies. With a significant focus on healthcare advancements and accessibility, Asia Pacific will emerge as the major contributor to the bionic eye industry, reflecting its crucial role in shaping the future of visual prosthetics.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Data collection
- 1.4 Forecast parameters
- 1.5 Data validation
- 1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing prevalence of vision loss and other chronic eye diseases
- 3.2.1.2 Increasing funding by private and public organizations
- 3.2.1.3 Rapid advancements in technological developments
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Low awareness among target population
- 3.2.2.2 High costs associated with these procedures
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Eye Type, 2018 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 External eye
- 5.3 Implanted eye
Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Electronic
- 6.3 Mechanical
- 6.4 Other technologies
Chapter 7 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Vision loss and impairment
- 7.3 Retinitis pigmentosa
- 7.4 Dry age-related macular degeneration
- 7.5 Other indications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Ophthalmic clinics
- 8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Bionic Eye Technologies, Inc.
- 10.2 Bionic Vision Technologies
- 10.3 iBionics
- 10.4 Monash Vision Group
- 10.5 Nidek Co. Ltd.
- 10.6 Optobionics
- 10.7 Pixium Vision SA
- 10.8 Schott
- 10.9 Second Sight Medical Products, Inc.
- 10.10 Vivani Medical, Inc.
